PD-L1, Galectin-9 and CD8<sup>+</sup> tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma.

Oncoimmunology · 2017 · PMC5353918 · PMID 28344887

Europe PMC DOI

hedged sentence

0.0920

closest p · 1.8× alpha

0.0920

boldest claim

The sentences

showed a trendp = 0.092so close (0.05 < p ≤ 0.1)

Low tumor CD8 + TIL count showed a trend toward poor HCC-specific survival ( p = 0.092), with a hazard ratio (HR 0.36, 95%CI 0.08–1.64) that was of similar magnitude and direction as in the discovery (EMC) cohort (HR 0.22, 95%CI 0.05–0.93).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.